Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - Translate Bio, Inc. | d867804dex322.htm |
EX-32.1 - EX-32.1 - Translate Bio, Inc. | d867804dex321.htm |
EX-31.2 - EX-31.2 - Translate Bio, Inc. | d867804dex312.htm |
EX-31.1 - EX-31.1 - Translate Bio, Inc. | d867804dex311.htm |
EX-21.1 - EX-21.1 - Translate Bio, Inc. | d867804dex211.htm |
EX-10.18 - EX-10.18 - Translate Bio, Inc. | d867804dex1018.htm |
EX-10.17 - EX-10.17 - Translate Bio, Inc. | d867804dex1017.htm |
EX-10.16 - EX-10.16 - Translate Bio, Inc. | d867804dex1016.htm |
EX-10.12 - EX-10.12 - Translate Bio, Inc. | d867804dex1012.htm |
EX-4.2 - EX-4.2 - Translate Bio, Inc. | d867804dex42.htm |
10-K - 10-K - Translate Bio, Inc. | d867804d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-226047 and No. 333-231746) and Form S-3 (No. 333-232543) of Translate Bio, Inc. of our report dated March 12, 2020 relating to the financial statements, which appears in this Annual Report on Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 12, 2020